Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245


Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patients.

Zheng Y, Wang DD, Wang W, Pan K, Huang CY, Li YF, Wang QJ, Yuan SQ, Jiang SS, Qiu HB, Chen YM, Zhang XF, Zhao BW, Mai C, Xia JC, Zhou ZW.

PLoS One. 2014 Apr 3;9(4):e93073. doi: 10.1371/journal.pone.0093073. eCollection 2014.


Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.

Kwon CH, Park HJ, Lee JR, Kim HK, Jeon TY, Jo HJ, Kim DH, Kim GH, Park DY.

Br J Cancer. 2014 Nov 11;111(10):1993-2002. doi: 10.1038/bjc.2014.490. Epub 2014 Sep 11.


Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY, Xing YN, Takahashi H, Takano Y, Zheng HC.

Tumour Biol. 2013 Apr;34(2):1071-83. doi: 10.1007/s13277-013-0648-8. Epub 2013 Jan 19.


Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.

Ito T, Yamada S, Tanaka C, Ito S, Murai T, Kobayashi D, Fujii T, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2014 Feb;21(2):560-8. doi: 10.1245/s10434-013-3246-5. Epub 2013 Sep 18.


Reduced expression of transcription factor AP-2α is associated with gastric adenocarcinoma prognosis.

Wang W, Lv L, Pan K, Zhang Y, Zhao JJ, Chen JG, Chen YB, Li YQ, Wang QJ, He J, Chen SP, Zhou ZW, Xia JC.

PLoS One. 2011;6(9):e24897. doi: 10.1371/journal.pone.0024897. Epub 2011 Sep 26.


Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.

Tang C, Gao X, Liu H, Jiang T, Zhai X.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):4782-94. eCollection 2014.


NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.

Shi R, Wang L, Wang T, Xu J, Wang F, Xu M.

Med Oncol. 2014 Mar;31(3):852. doi: 10.1007/s12032-014-0852-4. Epub 2014 Jan 28.


Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.

Xu XY, Gou WF, Yang X, Wang GL, Takahashi H, Yu M, Mao XY, Takano Y, Zheng HC.

Tumour Biol. 2012 Dec;33(6):1845-54. doi: 10.1007/s13277-012-0444-x. Epub 2012 Sep 5.


Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma.

Keshari RP, Wang W, Zhang Y, Wang DD, Li YF, Yuan SQ, Qiu HB, Huang CY, Chen YM, Xia JC, Zhou ZW.

PLoS One. 2014 Feb 4;9(2):e87195. doi: 10.1371/journal.pone.0087195. eCollection 2014.


Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.

Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR, Goel A.

Carcinogenesis. 2014 Dec;35(12):2731-9. doi: 10.1093/carcin/bgu200. Epub 2014 Oct 3.


Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.

Li G, Xu J, Wang Z, Yuan Y, Li Y, Cai S, He Y.

J Cancer Res Clin Oncol. 2015 Mar;141(3):443-52. doi: 10.1007/s00432-014-1838-5. Epub 2014 Sep 28.


Lin28 promotes Her2 expression and Lin28/Her2 predicts poorer survival in gastric cancer.

Wang Q, Zhou J, Guo J, Teng R, Shen J, Huang Y, Xie S, Wei Q, Zhao W, Chen W, Yuan X, Chen Y, Wang L.

Tumour Biol. 2014 Nov;35(11):11513-21. doi: 10.1007/s13277-014-2481-0. Epub 2014 Aug 16.


Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.

Chen DH, Yu JW, Wu JG, Wang SL, Jiang BJ.

J Cancer Res Clin Oncol. 2015 Dec;141(12):2109-20. doi: 10.1007/s00432-015-1973-7. Epub 2015 May 8.


Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.

Kong KL, Kwong DL, Fu L, Chan TH, Chen L, Liu H, Li Y, Zhu YH, Bi J, Qin YR, Law SY, Guan XY.

Cancer Res. 2010 Nov 1;70(21):8832-41. doi: 10.1158/0008-5472.CAN-10-0779. Epub 2010 Oct 26.


Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473. Epub 2011 Sep 22.


An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.

Sun GG, Sheng SH, Jing SW, Hu WN.

Tumour Biol. 2014 Mar;35(3):2641-8. doi: 10.1007/s13277-013-1347-1. Epub 2013 Nov 16.


Decreased expression of transcription elongation factor A-like 7 is associated with gastric adenocarcinoma prognosis.

Huang CY, Chen YM, Zhao JJ, Chen YB, Jiang SS, Yan SM, Zhao BW, Pan K, Wang DD, Lv L, Li YF, Wang W, Zhou ZW, Xia JC.

PLoS One. 2013;8(1):e54671. doi: 10.1371/journal.pone.0054671. Epub 2013 Jan 25.


Pyrophosphatase overexpression is associated with cell migration, invasion, and poor prognosis in gastric cancer.

Jeong SH, Ko GH, Cho YH, Lee YJ, Cho BI, Ha WS, Choi SK, Kim JW, Lee CW, Heo YS, Shin SH, Yoo J, Hong SC.

Tumour Biol. 2012 Dec;33(6):1889-98. doi: 10.1007/s13277-012-0449-5. Epub 2012 Jul 14.


High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.

Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ.

Ann Surg Oncol. 2010 Jan;17(1):89-97. doi: 10.1245/s10434-009-0722-z. Epub 2009 Oct 10.


Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.

Li P, Qian J, Yu G, Chen Y, Liu K, Li J, Wang J.

J Surg Oncol. 2012 Jan;105(1):31-7. doi: 10.1002/jso.22025. Epub 2011 Aug 30.

Items per page

Supplemental Content

Write to the Help Desk